Abstract

Purpose To cross-culturally adapt the Spinal Cord Injury Pain Instrument (SCIPI) into a simplified Chinese version (SC-SCIPI) and verify reliability and validity in screening for neuropathic pain in SCI patients. Methods A preliminary validation study was conducted to screen for neuropathic pain after SCI using SCIPI. A total of 130 patients with SCI treated at Shanghai Changhai Hospital were enrolled. Results for internal consistency, reliability and construct validity were compared with those of the Douleur Neuropathique (DN4), Leeds Assessment of Neuropathic Pain Questionnaire (LANSS), Neuropathic Pain Questionnaire (NPQ), ID Pain scale and VAS pain scale. Results The SCIPI was successfully translated into Chinese and expert consensus was reached on final adapted version of SC-SCIPI. For test-retest, SC-SCIPI total score was 2.35 ± 1.75 in first round and 2.35 ± 1.76 in second round. Cronbach α coefficient of SC-SCIPI was 0.909, indicating good internal consistency. Pearson correlation coefficient (r) showed that SC-SCIPI correlated well with LANSS, DN4, NPQ and ID pain; and correlated fairly well with VAS, indicating good construct validity. Conclusion SC-SCIPI demonstrates excellent internal consistency, reliability and good construct validity in Chinese patients with neuropathic pain, suggesting that SC-SCIPI is applicable in clinical practice to screen patients for neuropathic pain. IMPLICATION FOR REHABILITATION The Spinal Cord Injury pain Instrument has been cross-culturally adapted into a simplified Chinese version (SC-SCIPI). The SC-SCIPI showed excellent test-retest reliability and good construct validity. The 4-item SC-SCIPI is quite convenient to complete and it might be a useful instrument for routine application in patients with SCI for rehabilitation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call